BTGIN Signs Contract to Supply Rg3 Products to Danang Oncology Hospital in Vietnam
BTGIN Signs Contract to Supply Rg3 Products to Danang Oncology Hospital in Vietnam
BTGIN Signs Contract to Supply Rg3 Products to Danang Oncology Hospital in Vietnam
Introduction
BTGIN, a specialized enzyme red ginseng company, has recently signed a supply contract with Danang Oncology Hospital in Vietnam. This agreement involves the provision of supplements (Royal G3 300, Rg3 HSC) enhanced by red ginseng’s specific ginsenoside Rg3. These products were officially launched in Vietnam earlier this year after completing VFA certifications by the Vietnamese Ministry of Food and Drug Safety as health functional foods1.
Product Details
The supplements provided under this contract mainly contain the novel ginsenoside Rg3, which is well-known for its reported anticancer properties. BTGIN holds a patent for a ginsenoside formulation for lung cancer treatment, closely related to specific ginsenoside Rg3. According to worldwide clinical studies, ginsenoside Rg3 has shown promising results in cancer cell apoptosis, cancer cell growth inhibition, and metastasis inhibition in various cancers, including prostate, breast, ovarian, rectal, stomach, and liver cancers234.
Benefits of Ginsenoside Rg3
- Cancer Cell Apoptosis: Promotes the programmed death of cancer cells.
- Cancer Cell Growth Inhibition: Slows down or stops the proliferation of cancer cells.
- Metastasis Inhibition: Prevents the spread of cancer cells to other parts of the body.
- Angiogenesis Inhibition: Reduces the formation of new blood vessels that supply tumors, particularly in lung cancer.
Impact on Patients
Danang Oncology Hospital will provide these supplements to patients undergoing radio or chemotherapy who wish to use them. Vietnam has seen a significant increase in cancer cases, with 68,000 patients in 2000, 126,000 in 2010, and 165,000 in 2018. The cancer rate is 159.7 per 100,000 population, ranking 16th in Asia and 6th in Southeast Asia56. This contract is expected to help many patients in Vietnam.
Conclusion
BTGIN’s contract with Danang Oncology Hospital marks a significant step in providing advanced health functional foods to cancer patients in Vietnam. The use of ginsenoside Rg3 in these supplements offers potential benefits in cancer treatment and overall health support.
